121 related articles for article (PubMed ID: 7995048)
21. ACOG Practice Bulletin number 65: management of endometrial cancer.
Hernandez E;
Obstet Gynecol; 2006 Apr; 107(4):952; author reply 952-3. PubMed ID: 16582139
[No Abstract] [Full Text] [Related]
22. In vitro potentiation of radiation cytotoxicity by recombinant interferons in cervical cancer cell lines.
Angioli R; Sevin BU; Perras JP; Untch M; Koechli OR; Nguyen HN; Steren A; Schwade JG; Villani C; Averette HE
Cancer; 1993 Jun; 71(11):3717-25. PubMed ID: 8490922
[TBL] [Abstract][Full Text] [Related]
23. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy.
Clavero JM; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Barrette BA; Larson DR; Pairolero PC
Ann Thorac Surg; 2006 Jun; 81(6):2004-7. PubMed ID: 16731120
[TBL] [Abstract][Full Text] [Related]
24. Adenocarcinoma of the uterine cervix: a study of 37 cases.
Piura B; Dgani R; Yanai-Inbar I; Cohen Y; Glezerman M
J Surg Oncol; 1996 Apr; 61(4):249-55. PubMed ID: 8627993
[TBL] [Abstract][Full Text] [Related]
25. Sensitizing human cervical cancer cells In vitro to ionizing radiation with interferon beta or gamma.
Grüninger L; Cottin E; Li YX; Noël A; Ozsahin M; Coucke PA
Radiat Res; 1999 Nov; 152(5):493-8. PubMed ID: 10521926
[TBL] [Abstract][Full Text] [Related]
26. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
27. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of progesterone receptor levels by interferons in AE-7 endometrial cancer cells.
Angioli R; Untch M; Sevin BU; Steren A; Hightower RD; Perras JP; Nguyen HN; Koechli OR; Averette HE
Cancer; 1993 May; 71(9):2776-81. PubMed ID: 8467457
[TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance imaging of endometrial and cervical cancer.
Sahdev A; Reznek RH
Ann N Y Acad Sci; 2008 Sep; 1138():214-32. PubMed ID: 18837902
[TBL] [Abstract][Full Text] [Related]
30. [Locoregional recurrence of cervical and endometrial carcinoma: role of surgical resection].
Houvenaeghel G; Buttarelli M; Grégoire E; Moutardier V
Bull Cancer; 2005 Sep; 92(9):782-8. PubMed ID: 16203268
[TBL] [Abstract][Full Text] [Related]
31. Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements.
Kurbacher CM; Cree IA
Methods Mol Med; 2005; 110():101-20. PubMed ID: 15901931
[TBL] [Abstract][Full Text] [Related]
32. [Progesterone therapy of endometrial cancer].
Webb MJ
Gynakologe; 1993 Apr; 26(2):118-22. PubMed ID: 8508980
[No Abstract] [Full Text] [Related]
33. [Cancer of the uterine cervix in young women. A retrospective study of 337 cases].
Acharki A; Sahraoui S; Benider A; Tawfiq N; Jouhadi H; Bouras N; Samlali R; Kahlain A
Bull Cancer; 1997 Apr; 84(4):373-8. PubMed ID: 9238160
[TBL] [Abstract][Full Text] [Related]
34. Gynecologic malignancies.
Whitcomb BP
Surg Clin North Am; 2008 Apr; 88(2):301-17, vi. PubMed ID: 18381115
[TBL] [Abstract][Full Text] [Related]
35. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
[TBL] [Abstract][Full Text] [Related]
36. Isolation and characterization of a metastatic Eb-like tumor variant highly responsive to interleukin (IL)-2 and to combination cytokine therapy with IL-2/IL-1 beta and IL-1 beta/interferon-alpha/beta.
Gabriele L; Proietti E; Greco G; Venditti M; Gresser I; Schirrmacher V; Von Hoegen P; Testa U; Modesti A; Cianfriglia M
Invasion Metastasis; 1993; 13(3):147-62. PubMed ID: 8112975
[TBL] [Abstract][Full Text] [Related]
37. Endometrial carcinoma in a young obese patient.
Aslam MF; Joglekar V; Misra PK
J Obstet Gynaecol; 2005 Oct; 25(7):723-5. PubMed ID: 16263558
[No Abstract] [Full Text] [Related]
38. In vitro human tumor sensitivity assay using cell counting and sizing.
Lane FC; Mehta JR
Am Biotechnol Lab; 1990 Mar; 8(4):12-6, 18-24, 26-7. PubMed ID: 1366397
[No Abstract] [Full Text] [Related]
39. Clinical applicability of the ATP cell viability assay as a predictor of chemoresponse in platinum-resistant epithelial ovarian cancer using nonsurgical tumor cell samples.
Ng TY; Ngan HY; Cheng DK; Wong LC
Gynecol Oncol; 2000 Mar; 76(3):405-8. PubMed ID: 10684718
[TBL] [Abstract][Full Text] [Related]
40. [Double primary carcinoma of the uterine corpus and ovary].
Shen K
Zhonghua Fu Chan Ke Za Zhi; 1993 Apr; 28(4):227-9, 254. PubMed ID: 8404308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
